Article Topic
FDA Alert: More Counterfeit Ozempic found in U.S. Supply Chain
The FDA and Novo Nordisk are warning the public about counterfeit Ozempic injections circulating in the legitimate U.S. drug supply chain. The FDA announced the seizure of multiple batches of counterfeit Ozempic 1 mg injections, labeled with lot number PAR1229, on December 5, 2025. Their contents and safety are unverified and pose serious health risks.
[...]Prescription Drug Affordability Board Activity, October 2025
Prescription Drug Affordability Board Activity, October 2025 Activities Summary Colorado: Colorado’s PDAB heard testimony about its decision to set an upper payment limit on Enbrel, and set price of $600 per 50mg/1ml, effective January 1, 2027. The board’s next meeting was rescheduled from November 14, 2025 to January 9, 2026. Maryland: The PDAB will next…
[...]Five takeaways from CNBC’s investigation of alternative funding programs
What are the most important lessons from CNBC’s documentary about alternative funding programs (AFPs)?
[...]Plea Agreement, USA v Dhruv Ralhan, June 2023
United States Department of Justice Criminal Division, Fraud Section USA v Dhruv Ralhan Plea Agreement Filed June 2023 Read the document.
[...]Judgment, USA v Lazaro Hernandez, September 2023
United States District Court Southern District of Florida USA v Lazaro Hernandez Judgment Filed September 2023 Read the document.
[...]Verdict, USA v Charles Boyd, October 2025
United States District Court Southern District of Florida USA v Charles Boyd Verdict Filed October 30, 2025 Read the document.
[...]Complaint, USA v Adam Brosius, June 2024
United States District Court Southern District of Florida USA v Adam Brosius Complaint Filed June 2024 Read the document.
[...]PSM asks House Energy & Commerce Committee to oppose H.R. 5316, The Drug Shortage Compounding Patient Access Act
PSM sent a letter explaining how H.R. 5316 undermines critical patient safety protections.
[...]Prescription Drug Affordability Board Activity, September 2025
Prescription Drug Affordability Board Activity, September 2025 Activities Summary Colorado: Colorado’s next meeting will be October 3, 2025. Maryland: The PDAB met on September 29, 2025 to hear public comment about UPL-setting for Jardiance and Farxiga and to consider policy approaches to lower the costs of these drugs for Maryland patients. Oregon: The PDAB met…
[...]October 27, 2025: U.K. regulators bust illicit site making unlicensed retatrutide and tirzepatide pens
Authorities stated this was the largest single seizure of trafficked weight loss medicines worldwide.
[...]